Italian Council of State Suspends Oral CBD Restrictions and Refers Case to EU Court of Justice

Italy’s highest administrative court, the Council of State (Consiglio di Stato), issued Ordinance No. 6202/2026 suspending the Ministry of Health’s decree that classified oral CBD preparations as narcotic medicines. The court submitted five preliminary questions to the Court of Justice of the European Union (CJEU) under Article 267 TFUE to determine whether national restrictions on non-psychotropic cannabidiol violate European free movement principles.

Because the Italian court extended the decree’s suspension, oral CBD oils, capsules, and food supplements remain fully legal and freely available across Italian retail and online stores while the CJEU deliberates in Luxembourg.

Consiglio di Stato Referral and Free Movement of Goods

The Council of State concluded that there is no scientific evidence establishing that oral CBD possesses psychotropic properties or causes addiction. The Italian Ministry of Health had sought to place oral CBD extracts into Table B of its narcotics framework, requiring non-renewable medical prescriptions for every purchase.

By referring the matter to the Court of Justice of the European Union, the Italian judges asked Luxembourg to clarify several key principles under EU law:

Free Movement of Goods: Whether classifying non-intoxicating CBD as a prescription-only medicine constitutes an unlawful quantitative restriction under Article 34 of the Treaty on the Functioning of the European Union (TFUE).
The Precautionary Principle: Whether potential health concerns justify severe market restrictions when a substance lacks proven psychotropic or addictive risks.
Principle of Proportionality: Whether a blanket national restriction is proportionate when less restrictive safeguards, such as food safety limits and accurate packaging labels, are available.
Mutual Recognition: Whether a member state can restrict products that are lawfully manufactured and marketed in other EU member states under the precedent established in the CJEU Kanavape ruling (Case C-663/18).

What This Means for CBD Consumers in Italy and Europe

For consumers and retailers in Italy and across the European Union, the ruling provides immediate legal clarity and market continuity. The court’s order means that the government’s attempted prescription requirement remains on hold until the CJEU issues a final binding decision.

Key guidelines for European consumers include:

Continued Market Access: Natural oral CBD oils, tinctures, and wellness supplements can be lawfully purchased in Italy without a medical prescription.
Product Compliance: Ensure products contain less than 0.3% THC and originate from industrial hemp strains registered in the EU Common Catalogue.
Cross-Border Consistency: The CJEU ruling will set a binding precedent for all 27 EU member states regarding national attempts to restrict non-narcotic CBD.

To learn more about cannabinoid rules across member states, read our guide on whether CBD is legal in Europe.

Verified European CBD Brands and Safety Criteria

When shopping for CBD in Europe, select established manufacturers that provide independent batch Certificates of Analysis (COAs) from ISO/IEC 17025 accredited laboratories. Trusted European brands comply with current THC limits and food safety standards.

Below are verified European CBD suppliers offering compliant products:

Reakiro: Premium broad-spectrum CBD oils and capsules manufactured under strict European quality standards. Discover Reakiro CBD products.
Cibdol: Swiss-formulated broad-spectrum CBD drops and topicals with complete batch lab reports. Compare Cibdol CBD oils.
Nordic Oil: Organic European hemp extracts tested for purity and cannabinoid consistency. View Nordic Oil CBD options.
SWISS FX: High-purity broad-spectrum CBD formulations designed for everyday wellness. Explore SWISS FX CBD products.

Disclosure: cbd.eu.com provides independent editorial guidance. When you purchase through links on our site, we may earn an affiliate commission at no extra cost to you.

Frequently Asked Questions

Is oral CBD legal to buy in Italy without a prescription?

Yes. The Italian Council of State suspended the decree restricting oral CBD to prescription-only pharmacy distribution. Oral CBD products remain available in ordinary retail channels while the EU Court of Justice reviews the case.

What is the Italian Council of State referring to the EU Court of Justice?

The Council of State referred five questions to the CJEU under Ordinance 6202/2026 to determine whether national restrictions on non-psychotropic CBD violate EU free movement laws (Article 34 TFUE) and proportionality principles.

How long will the EU Court of Justice review take?

Preliminary rulings from the CJEU typically take between 12 and 18 months. During this entire period, the suspension of Italy’s restrictive decree remains in full effect.